Global Interventional Cardiology Market Growth 2020-2025

  • receipt Report ID : 61069
  • calendar_today Published On: Nov, 2020
  • file_copy Pages: 164
  • list Medical Devices
Buy @ $3660

According to this study, over the next five years the Interventional Cardiology market will register a 2.9%% CAGR in terms of revenue, the global market size will reach $ 3317.1 million by 2025, from $ 2964.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Interventional Cardiology business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Cardiology market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Interventional Cardiology, covering the supply chain analysis, impact assessment to the Interventional Cardiology market size growth rate in several scenarios, and the measures to be undertaken by Interventional Cardiology companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Cardiology Catheters

Guidewires

Balloon Catheters

Coronary Stents

Fractional Flow Reserve

Intravascular Ultrasound

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Hospitals

Clinics

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Medtronic, Inc.

Cordis Cashel

Boston Scientific Corporation

MINVASYS S.A.S.

BIOTRONIK SE & Co. KG

Abbott Vascular

KANEKA

Bard Peripheral Vascular_Inc

OrbusNeich Medical, BV

TERUMO CORPORATION

Kimal Plc

Lepu

Siemens Medical Solutions USA, Inc

MicroPort

Volcano Corporation

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Interventional Cardiology consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Interventional Cardiology market by identifying its various subsegments.

Focuses on the key global Interventional Cardiology manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Interventional Cardiology with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Interventional Cardiology submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Interventional Cardiology Consumption 2015-2025

2.1.2 Interventional Cardiology Consumption CAGR by Region

2.2 Interventional Cardiology Segment by Type

2.2.1 Cardiology Catheters

2.2.2 Guidewires

2.2.3 Balloon Catheters

2.2.4 Coronary Stents

2.2.5 Fractional Flow Reserve

2.2.6 Intravascular Ultrasound

2.3 Interventional Cardiology Consumption by Type

2.3.1 Global Interventional Cardiology Consumption Market Share by Type (2015-2020)

2.3.2 Global Interventional Cardiology Revenue and Market Share by Type (2015-2020)

2.3.3 Global Interventional Cardiology Sale Price by Type (2015-2020)

2.4 Interventional Cardiology Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 Interventional Cardiology Consumption by Application

2.5.1 Global Interventional Cardiology Consumption Market Share by Type (2015-2020)

2.5.2 Global Interventional Cardiology Value and Market Share by Type (2015-2020)

2.5.3 Global Interventional Cardiology Sale Price by Type (2015-2020)

3 Global Interventional Cardiology by Company

3.1 Global Interventional Cardiology Sales Market Share by Company

3.1.1 Global Interventional Cardiology Sales by Company (2018-2020)

3.1.2 Global Interventional Cardiology Sales Market Share by Company (2018-2020)

3.2 Global Interventional Cardiology Revenue Market Share by Company

3.2.1 Global Interventional Cardiology Revenue by Company (2018-2020)

3.2.2 Global Interventional Cardiology Revenue Market Share by Company (2018-2020)

3.3 Global Interventional Cardiology Sale Price by Company

3.4 Global Interventional Cardiology Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Interventional Cardiology Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Interventional Cardiology Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Interventional Cardiology by Regions

4.1 Interventional Cardiology by Regions

4.2 Americas Interventional Cardiology Consumption Growth

4.3 APAC Interventional Cardiology Consumption Growth

4.4 Europe Interventional Cardiology Consumption Growth

4.5 Middle East & Africa Interventional Cardiology Consumption Growth

5 Americas

5.1 Americas Interventional Cardiology Consumption by Countries

5.1.1 Americas Interventional Cardiology Consumption by Countries (2015-2020)

5.1.2 Americas Interventional Cardiology Value by Countries (2015-2020)

5.2 Americas Interventional Cardiology Consumption by Type

5.3 Americas Interventional Cardiology Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Interventional Cardiology Consumption by Regions

6.1.1 APAC Interventional Cardiology Consumption by Regions (2015-2020)

6.1.2 APAC Interventional Cardiology Value by Regions (2015-2020)

6.2 APAC Interventional Cardiology Consumption by Type

6.3 APAC Interventional Cardiology Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Interventional Cardiology by Countries

7.1.1 Europe Interventional Cardiology Consumption by Countries (2015-2020)

7.1.2 Europe Interventional Cardiology Value by Countries (2015-2020)

7.2 Europe Interventional Cardiology Consumption by Type

7.3 Europe Interventional Cardiology Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Interventional Cardiology by Countries

8.1.1 Middle East & Africa Interventional Cardiology Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Interventional Cardiology Value by Countries (2015-2020)

8.2 Middle East & Africa Interventional Cardiology Consumption by Type

8.3 Middle East & Africa Interventional Cardiology Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Interventional Cardiology Distributors

10.3 Interventional Cardiology Customer

11 Global Interventional Cardiology Market Forecast

11.1 Global Interventional Cardiology Consumption Forecast (2021-2025)

11.2 Global Interventional Cardiology Forecast by Regions

11.2.1 Global Interventional Cardiology Forecast by Regions (2021-2025)

11.2.2 Global Interventional Cardiology Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Interventional Cardiology Forecast by Type

11.8 Global Interventional Cardiology Forecast by Application

12 Key Players Analysis

12.1 Medtronic, Inc.

12.1.1 Company Information

12.1.2 Interventional Cardiology Product Offered

12.1.3 Medtronic, Inc. Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Medtronic, Inc. Latest Developments

12.2 Cordis Cashel

12.2.1 Company Information

12.2.2 Interventional Cardiology Product Offered

12.2.3 Cordis Cashel Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Cordis Cashel Latest Developments

12.3 Boston Scientific Corporation

12.3.1 Company Information

12.3.2 Interventional Cardiology Product Offered

12.3.3 Boston Scientific Corporation Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Boston Scientific Corporation Latest Developments

12.4 MINVASYS S.A.S.

12.4.1 Company Information

12.4.2 Interventional Cardiology Product Offered

12.4.3 MINVASYS S.A.S. Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 MINVASYS S.A.S. Latest Developments

12.5 BIOTRONIK SE & Co. KG

12.5.1 Company Information

12.5.2 Interventional Cardiology Product Offered

12.5.3 BIOTRONIK SE & Co. KG Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 BIOTRONIK SE & Co. KG Latest Developments

12.6 Abbott Vascular

12.6.1 Company Information

12.6.2 Interventional Cardiology Product Offered

12.6.3 Abbott Vascular Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Abbott Vascular Latest Developments

12.7 KANEKA

12.7.1 Company Information

12.7.2 Interventional Cardiology Product Offered

12.7.3 KANEKA Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 KANEKA Latest Developments

12.8 Bard Peripheral Vascular_Inc

12.8.1 Company Information

12.8.2 Interventional Cardiology Product Offered

12.8.3 Bard Peripheral Vascular_Inc Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Bard Peripheral Vascular_Inc Latest Developments

12.9 OrbusNeich Medical, BV

12.9.1 Company Information

12.9.2 Interventional Cardiology Product Offered

12.9.3 OrbusNeich Medical, BV Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 OrbusNeich Medical, BV Latest Developments

12.10 TERUMO CORPORATION

12.10.1 Company Information

12.10.2 Interventional Cardiology Product Offered

12.10.3 TERUMO CORPORATION Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 TERUMO CORPORATION Latest Developments

12.11 Kimal Plc

12.11.1 Company Information

12.11.2 Interventional Cardiology Product Offered

12.11.3 Kimal Plc Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 Kimal Plc Latest Developments

12.12 Lepu

12.12.1 Company Information

12.12.2 Interventional Cardiology Product Offered

12.12.3 Lepu Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 Lepu Latest Developments

12.13 Siemens Medical Solutions USA, Inc

12.13.1 Company Information

12.13.2 Interventional Cardiology Product Offered

12.13.3 Siemens Medical Solutions USA, Inc Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.13.4 Main Business Overview

12.13.5 Siemens Medical Solutions USA, Inc Latest Developments

12.14 MicroPort

12.14.1 Company Information

12.14.2 Interventional Cardiology Product Offered

12.14.3 MicroPort Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.14.4 Main Business Overview

12.14.5 MicroPort Latest Developments

12.15 Volcano Corporation

12.15.1 Company Information

12.15.2 Interventional Cardiology Product Offered

12.15.3 Volcano Corporation Interventional Cardiology Sales, Revenue, Price and Gross Margin (2018-2020)

12.15.4 Main Business Overview

12.15.5 Volcano Corporation Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Interventional Cardiology Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Cardiology Catheters

Table 5. Major Players of Guidewires

Table 6. Major Players of Balloon Catheters

Table 7. Major Players of Coronary Stents

Table 8. Major Players of Fractional Flow Reserve

Table 9. Major Players of Intravascular Ultrasound

Table 10. Global Consumption Sales by Type (2015-2020)

Table 11. Global Interventional Cardiology Consumption Market Share by Type (2015-2020)

Table 12. Global Interventional Cardiology Revenue by Type (2015-2020) ($ million)

Table 13. Global Interventional Cardiology Value Market Share by Type (2015-2020) ($ Millions)

Table 14. Global Interventional Cardiology Sale Price by Type (2015-2020)

Table 15. Global Consumption Sales by Application (2015-2020)

Table 16. Global Interventional Cardiology Consumption Market Share by Application (2015-2020)

Table 17. Global Interventional Cardiology Value by Application (2015-2020)

Table 18. Global Interventional Cardiology Value Market Share by Application (2015-2020)

Table 19. Global Interventional Cardiology Sale Price by Application (2015-2020)

Table 20. Global Interventional Cardiology Sales by Company (2017-2019) (K Units)

Table 21. Global Interventional Cardiology Sales Market Share by Company (2017-2019)

Table 22. Global Interventional Cardiology Revenue by Company (2017-2019) ($ Millions)

Table 23. Global Interventional Cardiology Revenue Market Share by Company (2017-2019)

Table 24. Global Interventional Cardiology Sale Price by Company (2017-2019)

Table 25. Global Interventional Cardiology Manufacturing Base Distribution and Sales Area by Manufacturers

Table 26. Players Interventional Cardiology Products Offered

Table 27. Interventional Cardiology Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 28. Global Interventional Cardiology Consumption by Regions 2015-2020 (K Units)

Table 29. Global Interventional Cardiology Consumption Market Share by Regions 2015-2020

Table 30. Global Interventional Cardiology Value by Regions 2015-2020 ($ Millions)

Table 31. Global Interventional Cardiology Value Market Share by Regions 2015-2020

Table 32. Americas Interventional Cardiology Consumption by Countries (2015-2020) (K Units)

Table 33. Americas Interventional Cardiology Consumption Market Share by Countries (2015-2020)

Table 34. Americas Interventional Cardiology Value by Countries (2015-2020) ($ Millions)

Table 35. Americas Interventional Cardiology Value Market Share by Countries (2015-2020)

Table 36. Americas Interventional Cardiology Consumption by Type (2015-2020) (K Units)

Table 37. Americas Interventional Cardiology Consumption Market Share by Type (2015-2020)

Table 38. Americas Interventional Cardiology Consumption by Application (2015-2020) (K Units)

Table 39. Americas Interventional Cardiology Consumption Market Share by Application (2015-2020)

Table 40. APAC Interventional Cardiology Consumption by Countries (2015-2020) (K Units)

Table 41. APAC Interventional Cardiology Consumption Market Share by Countries (2015-2020)

Table 42. APAC Interventional Cardiology Value by Regions (2015-2020) ($ Millions)

Table 43. APAC Interventional Cardiology Value Market Share by Regions (2015-2020)

Table 44. APAC Interventional Cardiology Consumption by Type (2015-2020) (K Units)

Table 45. APAC Interventional Cardiology Consumption Market Share by Type (2015-2020)

Table 46. APAC Interventional Cardiology Consumption by Application (2015-2020) (K Units)

Table 47. APAC Interventional Cardiology Consumption Market Share by Application (2015-2020)

Table 48. Europe Interventional Cardiology Consumption by Countries (2015-2020) (K Units)

Table 49. Europe Interventional Cardiology Consumption Market Share by Countries (2015-2020)

Table 50. Europe Interventional Cardiology Value by Countries (2015-2020) ($ Millions)

Table 51. Europe Interventional Cardiology Value Market Share by Countries (2015-2020)

Table 52. Europe Interventional Cardiology Consumption by Type (2015-2020) (K Units)

Table 53. Europe Interventional Cardiology Consumption Market Share by Type (2015-2020)

Table 54. Europe Interventional Cardiology Consumption by Application (2015-2020) (K Units)

Table 55. Europe Interventional Cardiology Consumption Market Share by Application (2015-2020)

Table 56. Middle East & Africa Interventional Cardiology Consumption by Countries (2015-2020) (K Units)

Table 57. Middle East & Africa Interventional Cardiology Consumption Market Share by Countries (2015-2020)

Table 58. Middle East & Africa Interventional Cardiology Value by Countries (2015-2020) ($ Millions)

Table 59. Middle East & Africa Interventional Cardiology Value Market Share by Countries (2015-2020)

Table 60. Middle East & Africa Interventional Cardiology Consumption by Type (2015-2020) (K Units)

Table 61. Middle East & Africa Interventional Cardiology Consumption Market Share by Type (2015-2020)

Table 62. Middle East & Africa Interventional Cardiology Consumption by Application (2015-2020) (K Units)

Table 63. Middle East & Africa Interventional Cardiology Consumption Market Share by Application (2015-2020)

Table 64. Interventional Cardiology Distributors List

Table 65. Interventional Cardiology Customer List

Table 66. Global Interventional Cardiology Consumption Forecast by Countries (2021-2025) (K Units)

Table 67. Global Interventional Cardiology Consumption Market Forecast by Regions

Table 68. Global Interventional Cardiology Value Forecast by Countries (2021-2025) ($ Millions)

Table 69. Global Interventional Cardiology Value Market Share Forecast by Regions

Table 70. Global Interventional Cardiology Consumption Forecast by Type (2021-2025) (K Units)

Table 71. Global Interventional Cardiology Consumption Market Share Forecast by Type (2021-2025)

Table 72. Global Interventional Cardiology Value Forecast by Type (2021-2025) ($ Millions)

Table 73. Global Interventional Cardiology Value Market Share Forecast by Type (2021-2025)

Table 74. Global Interventional Cardiology Consumption Forecast by Application (2021-2025) (K Units)

Table 75. Global Interventional Cardiology Consumption Market Share Forecast by Application (2021-2025)

Table 76. Global Interventional Cardiology Value Forecast by Application (2021-2025) ($ Millions)

Table 77. Global Interventional Cardiology Value Market Share Forecast by Application (2021-2025)

Table 78. Medtronic, Inc. Product Offered

Table 79. Medtronic, Inc. Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 80. Medtronic, Inc. Main Business

Table 81. Medtronic, Inc. Latest Developments

Table 82. Medtronic, Inc. Basic Information, Company Total Revenue (in $ million), Interventional Cardiology Manufacturing Base, Sales Area and Its Competitors

Table 83. Cordis Cashel Product Offered

Table 84. Cordis Cashel Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 85. Cordis Cashel Main Business

Table 86. Cordis Cashel Latest Developments

Table 87. Cordis Cashel Basic Information, Company Total Revenue (in $ million), Interventional Cardiology Manufacturing Base, Sales Area and Its Competitors

Table 88. Boston Scientific Corporation Product Offered

Table 89. Boston Scientific Corporation Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 90. Boston Scientific Corporation Main Business

Table 91. Boston Scientific Corporation Latest Developments

Table 92. Boston Scientific Corporation Basic Information, Company Total Revenue (in $ million), Interventional Cardiology Manufacturing Base, Sales Area and Its Competitors

Table 93. MINVASYS S.A.S. Product Offered

Table 94. MINVASYS S.A.S. Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 95. MINVASYS S.A.S. Main Business

Table 96. MINVASYS S.A.S. Latest Developments

Table 97. MINVASYS S.A.S. Basic Information, Company Total Revenue (in $ million), Interventional Cardiology Manufacturing Base, Sales Area and Its Competitors

Table 98. BIOTRONIK SE & Co. KG Product Offered

Table 99. BIOTRONIK SE & Co. KG Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 100. BIOTRONIK SE & Co. KG Main Business

Table 101. BIOTRONIK SE & Co. KG Latest Developments

Table 102. BIOTRONIK SE & Co. KG Basic Information, Company Total Revenue (in $ million), Interventional Cardiology Manufacturing Base, Sales Area and Its Competitors

Table 103. Abbott Vascular Product Offered

Table 104. Abbott Vascular Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 105. Abbott Vascular Main Business

Table 106. Abbott Vascular Latest Developments

Table 107. Abbott Vascular Basic Information, Company Total Revenue (in $ million), Interventional Cardiology Manufacturing Base, Sales Area and Its Competitors

Table 108. KANEKA Product Offered

Table 109. KANEKA Basic Information, Company Total Revenue (in $ million), Interventional Cardiology Manufacturing Base, Sales Area and Its Competitors

Table 110. KANEKA Main Business

Table 111. KANEKA Latest Developments

Table 112. KANEKA Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 113. Bard Peripheral Vascular_Inc Product Offered

Table 114. Bard Peripheral Vascular_Inc Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 115. Bard Peripheral Vascular_Inc Main Business

Table 116. Bard Peripheral Vascular_Inc Latest Developments

Table 117. Bard Peripheral Vascular_Inc Basic Information, Company Total Revenue (in $ million), Interventional Cardiology Manufacturing Base, Sales Area and Its Competitors

Table 118. OrbusNeich Medical, BV Product Offered

Table 119. OrbusNeich Medical, BV Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 120. OrbusNeich Medical, BV Main Business

Table 121. OrbusNeich Medical, BV Latest Developments

Table 122. OrbusNeich Medical, BV Basic Information, Company Total Revenue (in $ million), Interventional Cardiology Manufacturing Base, Sales Area and Its Competitors

Table 123. TERUMO CORPORATION Product Offered

Table 124. TERUMO CORPORATION Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 125. TERUMO CORPORATION Main Business

Table 126. TERUMO CORPORATION Latest Developments

Table 127. TERUMO CORPORATION Basic Information, Company Total Revenue (in $ million), Interventional Cardiology Manufacturing Base, Sales Area and Its Competitors

Table 128. Kimal Plc Product Offered

Table 129. Kimal Plc Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 130. Kimal Plc Main Business

Table 131. Kimal Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 132. Kimal Plc Latest Developments

Table 133. Lepu Product Offered

Table 134. Lepu Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 135. Lepu Main Business

Table 136. Lepu Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 137. Lepu Latest Developments

Table 138. Siemens Medical Solutions USA, Inc Product Offered

Table 139. Siemens Medical Solutions USA, Inc Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 140. Siemens Medical Solutions USA, Inc Main Business

Table 141. Siemens Medical Solutions USA, Inc Latest Developments

Table 142. Siemens Medical Solutions USA, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 143. MicroPort Product Offered

Table 144. MicroPort Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 145. MicroPort Main Business

Table 146. MicroPort Latest Developments

Table 147. MicroPort Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 148. Volcano Corporation Product Offered

Table 149. Volcano Corporation Interventional Cardiology Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 150. Volcano Corporation Main Business

Table 151. Volcano Corporation Latest Developments

Table 152. Volcano Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Interventional Cardiology

Figure 2. Interventional Cardiology Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Interventional Cardiology Consumption Growth Rate 2015-2025 (K Units)

Figure 5. Global Interventional Cardiology Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Cardiology Catheters

Figure 7. Product Picture of Guidewires

Figure 8. Product Picture of Balloon Catheters

Figure 9. Product Picture of Coronary Stents

Figure 10. Product Picture of Fractional Flow Reserve

Figure 11. Product Picture of Intravascular Ultrasound

Figure 12. Global Interventional Cardiology Consumption Market Share by Type (2015-2020)

Figure 13. Global Interventional Cardiology Value Market Share by Type (2015-2020)

Figure 14. Interventional Cardiology Consumed in Hospitals

Figure 15. Global Interventional Cardiology Market: Hospitals (2015-2020) (K Units)

Figure 16. Global Interventional Cardiology Market: Hospitals (2015-2020) ($ Millions)

Figure 17. Interventional Cardiology Consumed in Clinics

Figure 18. Global Interventional Cardiology Market: Clinics (2015-2020) (K Units)

Figure 19. Global Interventional Cardiology Market: Clinics (2015-2020) ($ Millions)

Figure 20. Interventional Cardiology Consumed in Others

Figure 21. Global Interventional Cardiology Market: Others (2015-2020) (K Units)

Figure 22. Global Interventional Cardiology Market: Others (2015-2020) ($ Millions)

Figure 23. Global Interventional Cardiology Consumption Market Share by Application (2015-2020)

Figure 24. Global Interventional Cardiology Value Market Share by Application (2015-2020)

Figure 25. Global Interventional Cardiology Sales Market Share by Company in 2017

Figure 26. Global Interventional Cardiology Sales Market Share by Company in 2019

Figure 27. Global Interventional Cardiology Revenue Market Share by Company in 2017

Figure 28. Global Interventional Cardiology Revenue Market Share by Company in 2019

Figure 29. Global Interventional Cardiology Sale Price by Company in 2019

Figure 30. Global Interventional Cardiology Consumption Market Share by Regions 2015-2020

Figure 31. Global Interventional Cardiology Value Market Share by Regions 2015-2020

Figure 32. Americas Interventional Cardiology Consumption 2015-2020 (K Units)

Figure 33. Americas Interventional Cardiology Value 2015-2020 ($ Millions)

Figure 34. APAC Interventional Cardiology Consumption 2015-2020 (K Units)

Figure 35. APAC Interventional Cardiology Value 2015-2020 ($ Millions)

Figure 36. Europe Interventional Cardiology Consumption 2015-2020 (K Units)

Figure 37. Europe Interventional Cardiology Value 2015-2020 ($ Millions)

Figure 38. Middle East & Africa Interventional Cardiology Consumption 2015-2020 (K Units)

Figure 39. Middle East & Africa Interventional Cardiology Value 2015-2020 ($ Millions)

Figure 40. Americas Interventional Cardiology Consumption Market Share by Countries in 2019

Figure 41. Americas Interventional Cardiology Value Market Share by Countries in 2019

Figure 42. Americas Interventional Cardiology Consumption Market Share by Type in 2019

Figure 43. Americas Interventional Cardiology Consumption Market Share by Application in 2019

Figure 44. United States Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 45. United States Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 46. Canada Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 47. Canada Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 48. Mexico Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 49. Mexico Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 50. APAC Interventional Cardiology Consumption Market Share by Countries in 2019

Figure 51. APAC Interventional Cardiology Value Market Share by Regions in 2019

Figure 52. APAC Interventional Cardiology Consumption Market Share by Type in 2019

Figure 53. APAC Interventional Cardiology Consumption Market Share by Application in 2019

Figure 54. China Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 55. China Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 56. Japan Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 57. Japan Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 58. Korea Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 59. Korea Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 60. Southeast Asia Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 61. Southeast Asia Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 62. India Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 63. India Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 64. Australia Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 65. Australia Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 66. Europe Interventional Cardiology Consumption Market Share by Countries in 2019

Figure 67. Europe Interventional Cardiology Value Market Share by Countries in 2019

Figure 68. Europe Interventional Cardiology Consumption Market Share by Type in 2019

Figure 69. Europe Interventional Cardiology Consumption Market Share by Application in 2019

Figure 70. Germany Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 71. Germany Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 72. France Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 73. France Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 74. UK Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 75. UK Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 76. Italy Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 77. Italy Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 78. Russia Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 79. Russia Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 80. Middle East & Africa Interventional Cardiology Consumption Market Share by Countries in 2019

Figure 81. Middle East & Africa Interventional Cardiology Value Market Share by Countries in 2019

Figure 82. Middle East & Africa Interventional Cardiology Consumption Market Share by Type in 2019

Figure 83. Middle East & Africa Interventional Cardiology Consumption Market Share by Application in 2019

Figure 84. Egypt Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 85. Egypt Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 86. South Africa Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 87. South Africa Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 88. Israel Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 89. Israel Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 90. Turkey Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 91. Turkey Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 92. GCC Countries Interventional Cardiology Consumption Growth 2015-2020 (K Units)

Figure 93. GCC Countries Interventional Cardiology Value Growth 2015-2020 ($ Millions)

Figure 94. Global Interventional Cardiology Consumption Growth Rate Forecast (2021-2025) (K Units)

Figure 95. Global Interventional Cardiology Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 96. Americas Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 97. Americas Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 98. APAC Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 99. APAC Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 100. Europe Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 101. Europe Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 102. Middle East & Africa Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 103. Middle East & Africa Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 104. United States Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 105. United States Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 106. Canada Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 107. Canada Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 108. Mexico Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 109. Mexico Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 110. Brazil Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 111. Brazil Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 112. China Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 113. China Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 114. Japan Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 115. Japan Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 116. Korea Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 117. Korea Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 118. Southeast Asia Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 119. Southeast Asia Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 120. India Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 121. India Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 122. Australia Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 123. Australia Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 124. Germany Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 125. Germany Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 126. France Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 127. France Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 128. UK Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 129. UK Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 130. Italy Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 131. Italy Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 132. Russia Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 133. Russia Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 134. Spain Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 135. Spain Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 136. Egypt Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 137. Egypt Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 138. South Africa Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 139. South Africa Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 140. Israel Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 141. Israel Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 142. Turkey Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 143. Turkey Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 144. GCC Countries Interventional Cardiology Consumption 2021-2025 (K Units)

Figure 145. GCC Countries Interventional Cardiology Value 2021-2025 ($ Millions)

Figure 146. Medtronic, Inc. Interventional Cardiology Market Share (2018-2020)

Figure 147. Cordis Cashel Interventional Cardiology Market Share (2018-2020)

Figure 148. Boston Scientific Corporation Interventional Cardiology Market Share (2018-2020)

Figure 149. MINVASYS S.A.S. Interventional Cardiology Market Share (2018-2020)

Figure 150. BIOTRONIK SE & Co. KG Interventional Cardiology Market Share (2018-2020)

Figure 151. Abbott Vascular Interventional Cardiology Market Share (2018-2020)

Figure 152. KANEKA Interventional Cardiology Market Share (2018-2020)

Figure 153. Bard Peripheral Vascular_Inc Interventional Cardiology Market Share (2018-2020)

Figure 154. OrbusNeich Medical, BV Interventional Cardiology Market Share (2018-2020)

Figure 155. TERUMO CORPORATION Interventional Cardiology Market Share (2018-2020)

Figure 156. Kimal Plc Interventional Cardiology Market Share (2018-2020)

Figure 157. Lepu Interventional Cardiology Market Share (2018-2020)

Figure 158. Siemens Medical Solutions USA, Inc Interventional Cardiology Market Share (2018-2020)

Figure 159. MicroPort Interventional Cardiology Market Share (2018-2020)

Figure 160. Volcano Corporation Interventional Cardiology Market Share (2018-2020)